title: Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma.
authors.forename: Tomohiko
authors.initials: T
authors.lastname: Kamimura
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Miyamoto
authors.forename: Shuichiro
authors.initials: S
authors.lastname: Takashima
authors.forename: Noriko
authors.initials: N
authors.lastname: Yokota
authors.forename: Yong
authors.initials: Y
authors.lastname: Chong
authors.forename: Yoshikiyo
authors.initials: Y
authors.lastname: Ito
authors.forename: Koichi
authors.initials: K
authors.lastname: Akashi
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001897:Boronic Acids / Q000008:administration & dosage / Q000009:adverse effects*; D000069286:Bortezomib; D004890:Erythema / Q000139:chemically induced; D006801:Humans; D007279:Injections, Subcutaneous; D009101:Multiple Myeloma / Q000188:drug therapy*; D010689:Phlebitis / Q000139:chemically induced; D011719:Pyrazines / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib